Labcorp Holdings Inc. has a robust position in the healthcare sector, providing essential diagnostic services. The recent trend indicates a stable growth pattern, making it an attractive option for long-term investors. However, potential investors should monitor the company's debt levels closely.
Labcorp Holdings shows a good fundamental rating of B+ with specific strengths in its Discounted Cash Flow and Returns ratios.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
Recent historical performance indicates stable overall scoring with certain strong metrics to be noted.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 6/25/2026 | 3 | 4 | 4 | 4 | 1 | 2 | 3 |
| Previous | 0 | 4 | 4 | 4 | 1 | 2 | 3 |
Analyst price targets project a stable forecast with a median price well-aligned with market expectations.
| High | Low | Median | Consensus |
|---|---|---|---|
| 334 | 300 | 300 | 311.33 |
The overall analyst sentiment is positive with strong buy recommendations prevailing.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 26 | |
| Hold | 9 | |
| Sell | 0 | |
| Strong Sell | 0 |
Labcorp Holdings Inc. offers a solid investment opportunity, with strong ratios in DCF and returns, appealing to long-term investors. The conservative debt levels require monitoring, but analyst consensus leans towards a positive outlook. Market stability is suggested by evenly distributed price targets. However, investors should keep an eye on industry changes and Labcorp's strategic response in this rapidly evolving market segment.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.